Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.
about
The application of the fibroblast activation protein α-targeted immunotherapy strategyQuantifying cellular interaction dynamics in 3D fluorescence microscopy data.Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment.Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancerIL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress.Intravital imaging of CD8+ T cell function in cancer.Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity.Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid TissuesMatrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.Positive and negative influence of the matrix architecture on antitumor immune surveillance.Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.The glioblastoma vasculature as a target for cancer therapy.Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies.Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.Endothelial plasticity governs the site-specific leukocyte recruitment in hepatocellular cancer.Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy.Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens.Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor ModelICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes
P2860
Q28073437-E969C9DB-3A30-406E-80F8-7BA61D9659F4Q33495521-E3DFC1EA-0244-4709-A0D3-715648E11003Q33925291-C12B0586-0499-4344-89B8-827043D07E32Q34989820-C25652C6-4B91-4417-8C6A-7A8074A73D8BQ35369944-B854D563-35A2-4C81-89F0-DD1E09FF15D3Q36038449-5121AC55-E184-4696-B5D2-34379039ACD9Q36471557-81CFEB1B-1890-4A2B-886C-3C680955DC78Q36557847-5CA4AB41-A99D-4305-9985-1E53F87EC72AQ36821063-6C0312B4-9DB8-4419-A16E-A11A3AC14B1EQ37063499-2D7B69F1-55CD-4703-ACE0-F55868C5D705Q37229840-BC70C7D8-3C48-4A85-BFA9-93E0E981A709Q37257207-76366FFE-88CA-4247-98D3-A0CF8D356863Q37274068-CAFE826B-F001-4E1F-9979-6F434FD14FF1Q37576573-A7CDF6B1-4C55-405E-A45A-57FD67AA7624Q37967510-114D2252-7563-43AC-8768-05FD379C6108Q38104594-CB7EC016-A5E1-4475-896A-DE10E6C79DB1Q38122205-2B7339F6-DF8C-4DB5-8E0C-B46950004497Q38268463-65EEDABA-C15B-42D5-8F65-AA9BDDC65E57Q38284345-96111EBC-A808-4180-9584-D3C82A8D66B9Q38289029-22D6B6EE-D082-491A-ACCB-F9F8E9F3D269Q38473933-E96359FC-5E48-47FA-B4F7-A7980CF8C630Q41483538-D0534F6B-B707-4138-B1FE-D6C432ACDADDQ43413284-E8213413-F95B-4EB8-96FD-2C41389CF465Q48892878-D564078A-91FE-4DAC-B78A-926418372071Q55262681-9B8F0E9F-CF1E-4E7B-AE28-054A621E0B49Q58731923-FC1FB818-C82D-468A-BDF7-90CF0A2859E7Q58746560-537E3AE1-70A7-481F-9558-4279FE5A9DA5
P2860
Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hurdles to lymphocyte traffick ...... s for effective immunotherapy.
@ast
Hurdles to lymphocyte traffick ...... s for effective immunotherapy.
@en
type
label
Hurdles to lymphocyte traffick ...... s for effective immunotherapy.
@ast
Hurdles to lymphocyte traffick ...... s for effective immunotherapy.
@en
prefLabel
Hurdles to lymphocyte traffick ...... s for effective immunotherapy.
@ast
Hurdles to lymphocyte traffick ...... s for effective immunotherapy.
@en
P2093
P2860
P1476
Hurdles to lymphocyte traffick ...... s for effective immunotherapy.
@en
P2093
Daniel T Fisher
Joseph Skitzki
Michelle M Appenheimer
Sharon S Evans
Wan-Chao Wang
P2860
P304
P356
10.1080/08820130600745430
P50
P577
2006-01-01T00:00:00Z